Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MRM
MRM logo

MRM Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
1.250
Open
1.230
VWAP
1.23
Vol
36.62K
Mkt Cap
9.88M
Low
1.185
Amount
44.98K
EV/EBITDA(TTM)
25.62
Total Shares
7.90M
EV
25.10M
EV/OCF(TTM)
--
P/S(TTM)
0.16
Medirom Healthcare Technologies Inc is a Japan-based holistic health services provider. The Company is a franchiser and operator of healthcare salons across Japan and is a preferred platform partner for large consumer brands, healthcare service providers and government entities. The Company mainly operates in two business segments. The Relaxation Salon Segment is engaged in the development of relaxation studios nationwide, centered on Re.Ra.Ku for the purpose of health management services. The Digital Preventative Healthcare Segment is involved in the sampling business, which includes brand promotion and consumer analysis for third party brands of corporate clients, government-sponsored specific health guidance program, utilizing internally-developed on-demand health monitoring smartphone application Lav, as well as MOTHER Tracker for fitness applications, and preventative healthcare services utilizing digital application and devices.
Show More

Events Timeline

(ET)
2026-02-27
08:10:00
Medirom Healthcare Signs Agreement with Tools for Humanity, Projects $39 Million Income Over Two Years
select
2025-12-29 (ET)
2025-12-29
08:30:00
MEDIROM Collaborates with World Foundation to Deploy Proof of Human Technology in Japan
select
2025-12-26 (ET)
2025-12-26
18:00:00
Medirom Healthcare Partners with World Foundation to Deploy Proof of Human Technology
select
2025-10-29 (ET)
2025-10-29
10:25:23
Medirom Healthcare to Introduce New Treasury Strategy Utilizing Cryptocurrency
select
2025-10-28 (ET)
2025-10-28
08:36:02
Medirom Healthcare reports that more than 10,000 individuals have obtained World IDs at various locations.
select
2025-10-09 (ET)
2025-10-09
08:08:59
Medirom Mother Labs Secures Funding from Internal Investors
select
2025-09-18 (ET)
2025-09-18
17:03:43
Japan's Ground Self-Defense Force Implements Medirom Remony Health Monitoring System
select
2025-05-30 (ET)
2025-05-30
09:05:24
Medirom Mother Labs surpasses 100 companies in health guidance service
select
2025-05-20 (ET)
2025-05-20
09:00:55
Medirom Healthcare reports FY24 EPS 17c vs. 15c last year
select

News

Newsfilter
7.5
02-27Newsfilter
MEDIROM Partners with Tools for Humanity Under New Agreement
  • Agreement Activation: MEDIROM Healthcare Technologies announced that the Master Service Agreement with Tools for Humanity and World Foundation became effective on February 2, 2026, marking a significant step in the company's strategic collaboration in the health tech sector.
  • Market Expansion Plans: Currently, Orbs are installed at over 150 locations, primarily at MEDIROM's 'Re.Ra.Ku' relaxation studios, with plans to expand to approximately 3,000 locations nationwide, significantly enhancing market coverage.
  • Revenue Projections: Based on current authentication performance, MEDIROM estimates it could generate approximately $39 million (around JPY 6.10 billion) in income before taxes over the next two years, providing robust support for the company's financial health and sustained growth.
  • Innovation Background: Since 2015, MEDIROM has been expanding its health tech business, launching innovative products such as the Lav® app and MOTHER Bracelet®, demonstrating its ongoing commitment and growth potential in the digital preventative healthcare space.
Yahoo Finance
8.5
01-14Yahoo Finance
Micromem Technologies Closes C$327,778 Private Placement
  • Successful Private Placement: Micromem Technologies has closed a non-brokered private placement, raising approximately C$327,778 by issuing 6,555,555 units at C$0.05 each, indicating market confidence in its financing needs.
  • Clear Use of Proceeds: The funds raised will be allocated for working capital, reflecting Micromem's strategic intent to enhance its intelligent application development capabilities, particularly in sectors like oil & gas and healthcare.
  • Compliance Requirements: The securities issued are subject to post-closing compliance requirements from the Canadian Securities Exchange, ensuring the company operates within legal frameworks and bolstering investor confidence.
  • Future Financing Potential: Micromem may close an additional tranche of up to C$167,000 as needed, demonstrating the company's proactive planning for future capital requirements to further support its business growth.
Businesswire
9.0
01-09Businesswire
MRM Health Receives FDA Clearance to Initiate MH002 Clinical Trial
  • Clinical Trial Launch: MRM Health's MH002 program has received FDA clearance, marking the initiation of the STARFISH-UC Phase 2b clinical trial, which is expected to enroll approximately 204 patients with mild-to-moderate ulcerative colitis, advancing the development of next-generation therapies for inflammatory bowel diseases.
  • Efficacy Validation: MH002 demonstrated excellent safety and encouraging efficacy in its Phase 2a trial, with significant mucosal healing and anti-inflammatory effects observed after 8 weeks of treatment, laying a solid foundation for the upcoming Phase 2b trial.
  • Innovative Technology Platform: MH002 is designed and manufactured using MRM Health's CORAL® platform, ensuring drug consistency and high quality, which supports cost-effective treatments for chronic inflammatory conditions and holds significant market potential.
  • Funding Support: MRM Health successfully closed a €55 million Series B round in September 2025, enhancing its R&D capabilities in inflammatory diseases and providing financial backing for future clinical advancements.
Globenewswire
3.5
01-08Globenewswire
MEDIROM Surpasses 20,000 Human Authentications with 'Orb' Device
  • Surge in Authentications: As of December 28, 2025, MEDIROM has surpassed 20,000 human authentications using the 'Orb' device at its subsidiary's 'Re.Ra.Ku' relaxation salons, doubling from 10,000 cases on October 23, 2025, indicating rapid growth potential in digital infrastructure.
  • Event-Driven Growth: The spike in authentications was largely driven by the company's 25th anniversary event, ‘The 5-Minute Shoulder Massage Campaign for 250,000 People,’ which attracted significant customer interest by offering free shoulder massages, facilitating rapid technology adoption.
  • Nationwide Expansion Plans: MEDIROM aims to install 'Orb' devices in 200 salons across the country, progressively broadening access to this new social infrastructure, thereby enhancing customer experience and competitive positioning in the market.
  • Strategic Partnership Outlook: MEDIROM's involvement in the 'World' project, aimed at creating the largest network of real humans, positions the company favorably for future developments in digital infrastructure, driving ongoing growth in the health tech sector.
Globenewswire
3.5
2025-12-29Globenewswire
MEDIROM Partners with Tools for Humanity to Launch Proof of Human Technology in Japan
  • Agreement Signed: MEDIROM has entered into a Master Service Agreement with Tools for Humanity and World Foundation to operate Proof of Human verification locations in Japan, which is expected to gradually increase revenue through operational fees and related services, driving the company's transformation in the health tech sector.
  • Technology Deployment Plan: MEDIROM will introduce advanced privacy-preserving technology, “Orbs,” in approximately 300 Re.Ra.Ku locations, enhancing the credibility of human verification while boosting customer trust in the digital society, thereby promoting diversified business development.
  • Task Force Establishment: To support the nationwide rollout of Proof of Human technology, MEDIROM has established the “MEDIROM World Proof of Human Task Force,” which will strengthen its organizational structure to ensure rapid deployment and effective operation of the technology, further solidifying its leadership in the health tech field.
  • Social Impact Enhancement: This collaboration not only opens new revenue models for MEDIROM but also contributes to building trust within Japan's digital society, aligning with the global demand for human identity verification and showcasing the company's foresight in technological innovation and social responsibility.
Globenewswire
3.5
2025-12-26Globenewswire
MEDIROM Partners with Tools for Humanity to Launch Proof of Human Technology in Japan
  • Master Service Agreement Signed: MEDIROM has entered into a Master Service Agreement with Tools for Humanity and World Foundation to operate Proof of Human verification locations in Japan, which is expected to gradually enhance the company's revenue through operational fees and related services.
  • Technology Deployment Plan: MEDIROM will introduce advanced privacy-preserving Orbs in approximately 300 Re.Ra.Ku locations, enabling rapid and trusted human verification, thereby enhancing customer trust and expanding market reach.
  • Organizational Structure Optimization: To support the nationwide rollout of Proof of Human technology, MEDIROM has established a dedicated “Proof of Human Task Force,” strengthening its organizational structure to adapt to the new business model and drive its transformation into a health tech company.
  • Social Impact Outlook: Through collaboration with Tools for Humanity, MEDIROM aims to establish a trusted digital society infrastructure that encourages participation in the digital society, further elevating the company's position in the health tech industry.

Valuation Metrics

The current forward P/E ratio for Medirom Healthcare Technologies Inc (MRM.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Medirom Healthcare Technologies Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
2.38
Current EV/EBITDA
15.46
Overvalued EV/EBITDA
7.29
Undervalued EV/EBITDA
-2.52

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.04
Current PS
0.27
Overvalued PS
0.12
Undervalued PS
-0.05

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

Oversold Mean Reversion
Intellectia · 1236 candidates
Rsi Category: moderate, oversoldList Exchange: XNYS, XNAS, XASEWeek Price Change Pct: <= $-1.00Monthly Average Dollar Volume: >= 50,000
Ticker
Name
Market Cap$
top bottom
KEP logo
KEP
Korea Electric Power Corp
27.00B
GLAD logo
GLAD
Gladstone Capital Corp
458.87M
STNG logo
STNG
Scorpio Tankers Inc
3.02B
TGL logo
TGL
Treasure Global Inc
7.92M
SCLX logo
SCLX
Scilex Holding Co
82.96M
PCH logo
PCH
Potlatchdeltic Corp
3.39B
penny stocks with most growth potential
Intellectia · 16 candidates
Market Cap: <= 2.00BPrice: <= $5.00Revenue 5yr Cagr: >= 0Eps 5yr Cagr: >= 0Annual Revenue Yoy Growth: >= 0.0%
Ticker
Name
Market Cap$
top bottom
GTN logo
GTN
Gray Media Inc
455.31M
HKD logo
HKD
AMTD Digital Inc
446.28M
AUNA logo
AUNA
Auna SA
364.88M
MNTK logo
MNTK
Montauk Renewables Inc
219.08M
CAAS logo
CAAS
China Automotive Systems Inc
137.28M
SIEB logo
SIEB
Siebert Financial Corp
123.71M
penny stocks with most frowth potential
Intellectia · 16 candidates
Market Cap: <= 2.00BPrice: <= $5.00Revenue 5yr Cagr: >= 0Eps 5yr Cagr: >= 0Annual Revenue Yoy Growth: >= 0.0%
Ticker
Name
Market Cap$
top bottom
GTN logo
GTN
Gray Media Inc
455.31M
HKD logo
HKD
AMTD Digital Inc
446.28M
AUNA logo
AUNA
Auna SA
364.88M
MNTK logo
MNTK
Montauk Renewables Inc
219.08M
CAAS logo
CAAS
China Automotive Systems Inc
137.28M
SIEB logo
SIEB
Siebert Financial Corp
123.71M
penny stocks with a future
Intellectia · 13 candidates
Market Cap: <= 2.00BPrice: <= $5.00Revenue 5yr Cagr: >= 2Eps 5yr Cagr: >= 2Annual Revenue Yoy Growth: >= 2.0%
Ticker
Name
Market Cap$
top bottom
GTN logo
GTN
Gray Media Inc
455.31M
AUNA logo
AUNA
Auna SA
364.88M
CAAS logo
CAAS
China Automotive Systems Inc
137.28M
SIEB logo
SIEB
Siebert Financial Corp
123.71M
UHG logo
UHG
United Homes Group Inc
98.22M
SFWL logo
SFWL
SHENGFENG DEVELOPMENT Ltd
78.32M

Whales Holding MRM

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Medirom Healthcare Technologies Inc (MRM) stock price today?

The current price of MRM is 1.25 USD — it has increased 1.63

What is Medirom Healthcare Technologies Inc (MRM)'s business?

Medirom Healthcare Technologies Inc is a Japan-based holistic health services provider. The Company is a franchiser and operator of healthcare salons across Japan and is a preferred platform partner for large consumer brands, healthcare service providers and government entities. The Company mainly operates in two business segments. The Relaxation Salon Segment is engaged in the development of relaxation studios nationwide, centered on Re.Ra.Ku for the purpose of health management services. The Digital Preventative Healthcare Segment is involved in the sampling business, which includes brand promotion and consumer analysis for third party brands of corporate clients, government-sponsored specific health guidance program, utilizing internally-developed on-demand health monitoring smartphone application Lav, as well as MOTHER Tracker for fitness applications, and preventative healthcare services utilizing digital application and devices.

What is the price predicton of MRM Stock?

Wall Street analysts forecast MRM stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MRM is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Medirom Healthcare Technologies Inc (MRM)'s revenue for the last quarter?

Medirom Healthcare Technologies Inc revenue for the last quarter amounts to NaN USD, decreased

What is Medirom Healthcare Technologies Inc (MRM)'s earnings per share (EPS) for the last quarter?

Medirom Healthcare Technologies Inc. EPS for the last quarter amounts to USD, decreased

How many employees does Medirom Healthcare Technologies Inc (MRM). have?

Medirom Healthcare Technologies Inc (MRM) has 334 emplpoyees as of March 21 2026.

What is Medirom Healthcare Technologies Inc (MRM) market cap?

Today MRM has the market capitalization of 9.88M USD.